NasdaqCM · Biotechnology

Whitehawk Therapeutics (WHWK)

Stock, pipeline and biotech catalyst intelligence

Analyst view

Buy+58.6%

$7.50 average target

$4.73-0.10 (-2.1%)Latest market snapshot · Yahoo Finance

Market cap$269.7M

Cash$190.0M

Quarterly burn$14.5M

Pipeline assets3

Short float12.5%

Market context

WHWK Stock Chart

Loading interactive chart…

Chart provided by TradingView. Market data may be delayed.

Next catalyst

HWK-016 (MUC16 Targeted ADC)

Jun 30, 2027 · Data readout

View pipeline & catalysts

Company profile

About Whitehawk Therapeutics

Whitehawk Therapeutics, Inc., a clinical-stage oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments. It provides three next generation antibody drug conjugates (ADC) portfolio to treat cancer. The company was formerly known as Aadi Bioscience, Inc. and changed its name to Whitehawk Therapeutics, Inc. in August 2021. Whitehawk Therapeutics, Inc. was incorporated in 2007 and is headquartered in Morristown, New Jersey.

Company profile supplied by Yahoo Finance. Catalyst dates can change and should be confirmed against the linked primary source.

Page updated Aug 21, 2026 · Yahoo quotes cached for one minute; reference data may be used when a live field is unavailable.